Education
About Us
Working with TipRanks
Follow Us
PRIM, S.A. (DE:5P1)
:5P1
5P1 Stock Chart & Stats
Day’s Range― - ―
52-Week Range€9.16 - €12.45
Previous CloseN/A
Volume0.00
Average Volume (3M)77.00
Market Cap
€205.08M
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)15.5
Beta0.22
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding17,036,577
10 Day Avg. Volume102
30 Day Avg. Volume77
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
PRIM, S.A. News
5P1 FAQ
What was PRIM, S.A.’s price range in the past 12 months?
PRIM, S.A. lowest stock price was €9.16 and its highest was €12.45 in the past 12 months.
What is PRIM, S.A.’s market cap?
PRIM, S.A.’s market cap is €205.08M.
When is PRIM, S.A.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were PRIM, S.A.’s earnings last quarter?
Currently, no data Available
Is PRIM, S.A. overvalued?
According to Wall Street analysts PRIM, S.A.’s price is currently Overvalued.
Does PRIM, S.A. pay dividends?
PRIM, S.A. does not currently pay dividends.
What is PRIM, S.A.’s EPS estimate?
PRIM, S.A.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does PRIM, S.A. have?
PRIM, S.A. has 17,036,577 shares outstanding.
What happened to PRIM, S.A.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of PRIM, S.A.?
Currently, no hedge funds are holding shares in DE:5P1
Company Description
PRIM, S.A.
Prim, S.A., through its subsidiaries, designs, manufactures, and commercializes orthopedic products for physiotherapy, thalassotherapy, hydrotherapy, rehabilitation, spa, geriatrics, and support techniques in Spain and internationally. The company offers products for neuro-trauma, cardiovascular, neuromodulation, operating rooms, endo-surgery, plastic surgery, and ENT. It also engages in management of wellness projects, including hotels, resorts, and club sports. Prim, S.A. was founded in 1870 and is headquartered in Móstoles, Spain.
PRIM, S.A. (5P1) Earnings & Revenues
Currently, no data available
Please return soon. This page is being updated.
Technical Analysis
Clinica Baviera
―
LABORATORIO REIG JOFRE
―
Oryzon Genomics SA
―
Atrys Health SA
―
Labiana Health SA
―
Ownership Overview
―
Insiders
8.51%
Mutual Funds
― Other Institutional Investors
91.49% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---